Synthesis and properties of GuNA purine/pyrimidine nucleosides and oligonucleotides

We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and...

Full description

Saved in:
Bibliographic Details
Published inOrganic & biomolecular chemistry Vol. 18; no. 46; pp. 9461 - 9472
Main Authors Kumagai, Shinji, Sawamoto, Hiroaki, Takegawa-Araki, Tomo, Arai, Yuuki, Yamakoshi, Shuhei, Yamada, Katsuya, Ohta, Tetsuya, Kawanishi, Eiji, Horie, Naohiro, Yamaguchi, Takao, Obika, Satoshi
Format Journal Article
LanguageEnglish
Published CAMBRIDGE Royal Soc Chemistry 07.12.2020
Royal Society of Chemistry
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and were highly stable against 3′-exonuclease. Therefore, GuNA is a promissing artificial nucleic acid for therapeutic antisense oligonucleotides. We herein report the facile synthesis of GuNA phosphoramidites bearing adenine (A), guanine (G), and 5-methylcytosine ( m C) nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides, even with sequences having acid-sensitive purine nucleobases. Oligonucleotides modified with GuNA-A, -G, or - m C possessed high duplex-forming ability, similar to those modified with GuNA-T. Moreover, some of the GuNA-modified oligonucleotides were revealed to have high base discriminating ability compared with that of their natural counterparts. GuNA nucleosides exhibited no genotoxicity in bacterial reverse mutation assays. Thus, all GuNAs (GuNA-T, -A, -G, and - m C) are now available to be examined in therapeutic applications. Facile synthesis of GuNA (guanidine-bridged nucleic acid) phosphoramidites bearing thymine, adenine, guanine, and 5-methylcytosine nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides are described.
AbstractList We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and were highly stable against 3′-exonuclease. Therefore, GuNA is a promissing artificial nucleic acid for therapeutic antisense oligonucleotides. We herein report the facile synthesis of GuNA phosphoramidites bearing adenine (A), guanine (G), and 5-methylcytosine ( m C) nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides, even with sequences having acid-sensitive purine nucleobases. Oligonucleotides modified with GuNA-A, -G, or - m C possessed high duplex-forming ability, similar to those modified with GuNA-T. Moreover, some of the GuNA-modified oligonucleotides were revealed to have high base discriminating ability compared with that of their natural counterparts. GuNA nucleosides exhibited no genotoxicity in bacterial reverse mutation assays. Thus, all GuNAs (GuNA-T, -A, -G, and - m C) are now available to be examined in therapeutic applications.
We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and were highly stable against 3′-exonuclease. Therefore, GuNA is a promissing artificial nucleic acid for therapeutic antisense oligonucleotides. We herein report the facile synthesis of GuNA phosphoramidites bearing adenine (A), guanine (G), and 5-methylcytosine ( m C) nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides, even with sequences having acid-sensitive purine nucleobases. Oligonucleotides modified with GuNA-A, -G, or - m C possessed high duplex-forming ability, similar to those modified with GuNA-T. Moreover, some of the GuNA-modified oligonucleotides were revealed to have high base discriminating ability compared with that of their natural counterparts. GuNA nucleosides exhibited no genotoxicity in bacterial reverse mutation assays. Thus, all GuNAs (GuNA-T, -A, -G, and - m C) are now available to be examined in therapeutic applications. Facile synthesis of GuNA (guanidine-bridged nucleic acid) phosphoramidites bearing thymine, adenine, guanine, and 5-methylcytosine nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides are described.
We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and were highly stable against 3'-exonuclease. Therefore, GuNA is a promissing artificial nucleic acid for therapeutic antisense oligonucleotides. We herein report the facile synthesis of GuNA phosphoramidites bearing adenine (A), guanine (G), and 5-methylcytosine (mC) nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides, even with sequences having acid-sensitive purine nucleobases. Oligonucleotides modified with GuNA-A, -G, or -mC possessed high duplex-forming ability, similar to those modified with GuNA-T. Moreover, some of the GuNA-modified oligonucleotides were revealed to have high base discriminating ability compared with that of their natural counterparts. GuNA nucleosides exhibited no genotoxicity in bacterial reverse mutation assays. Thus, all GuNAs (GuNA-T, -A, -G, and -mC) are now available to be examined in therapeutic applications.We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and were highly stable against 3'-exonuclease. Therefore, GuNA is a promissing artificial nucleic acid for therapeutic antisense oligonucleotides. We herein report the facile synthesis of GuNA phosphoramidites bearing adenine (A), guanine (G), and 5-methylcytosine (mC) nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides, even with sequences having acid-sensitive purine nucleobases. Oligonucleotides modified with GuNA-A, -G, or -mC possessed high duplex-forming ability, similar to those modified with GuNA-T. Moreover, some of the GuNA-modified oligonucleotides were revealed to have high base discriminating ability compared with that of their natural counterparts. GuNA nucleosides exhibited no genotoxicity in bacterial reverse mutation assays. Thus, all GuNAs (GuNA-T, -A, -G, and -mC) are now available to be examined in therapeutic applications.
We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and were highly stable against 3'-exonuclease. Therefore, GuNA is a promissing artificial nucleic acid for therapeutic antisense oligonucleotides. We herein report the facile synthesis of GuNA phosphoramidites bearing adenine (A), guanine (G), and 5-methylcytosine (mC) nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides, even with sequences having acid-sensitive purine nucleobases. Oligonucleotides modified with GuNA-A, -G, or -mC possessed high duplex-forming ability, similar to those modified with GuNA-T. Moreover, some of the GuNA-modified oligonucleotides were revealed to have high base discriminating ability compared with that of their natural counterparts. GuNA nucleosides exhibited no genotoxicity in bacterial reverse mutation assays. Thus, all GuNAs (GuNA-T, -A, -G, and -mC) are now available to be examined in therapeutic applications.
We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into oligonucleotides. The GuNA-T-modified oligonucleotides possessed high duplex-forming ability towards their complementary single-stranded RNAs and were highly stable against 3 ' -exonuclease. Therefore, GuNA is a promissing artificial nucleic acid for therapeutic antisense oligonucleotides. We herein report the facile synthesis of GuNA phosphoramidites bearing adenine (A), guanine (G), and 5-methylcytosine (C-m) nucleobases and a robust method for the preparation of GuNA-modified oligonucleotides, even with sequences having acid-sensitive purine nucleobases. Oligonucleotides modified with GuNA-A, -G, or -C-m possessed high duplex-forming ability, similar to those modified with GuNA-T. Moreover, some of the GuNA-modified oligonucleotides were revealed to have high base discriminating ability compared with that of their natural counterparts. GuNA nucleosides exhibited no genotoxicity in bacterial reverse mutation assays. Thus, all GuNAs (GuNA-T, -A, -G, and -C-m) are now available to be examined in therapeutic applications.
Author Yamakoshi, Shuhei
Obika, Satoshi
Sawamoto, Hiroaki
Arai, Yuuki
Yamada, Katsuya
Ohta, Tetsuya
Yamaguchi, Takao
Horie, Naohiro
Kawanishi, Eiji
Kumagai, Shinji
Takegawa-Araki, Tomo
AuthorAffiliation Health and Nutrition (NIBIOHN)
Osaka University
Graduate School of Pharmaceutical Sciences
Sohyaku. Innovative Research Division
Mitsubishi Tanabe Pharma Corporation
National Institutes of Biomedical Innovation
AuthorAffiliation_xml – name: Health and Nutrition (NIBIOHN)
– name: Sohyaku. Innovative Research Division
– name: Osaka University
– name: Graduate School of Pharmaceutical Sciences
– name: National Institutes of Biomedical Innovation
– name: Mitsubishi Tanabe Pharma Corporation
Author_xml – sequence: 1
  givenname: Shinji
  surname: Kumagai
  fullname: Kumagai, Shinji
– sequence: 2
  givenname: Hiroaki
  surname: Sawamoto
  fullname: Sawamoto, Hiroaki
– sequence: 3
  givenname: Tomo
  surname: Takegawa-Araki
  fullname: Takegawa-Araki, Tomo
– sequence: 4
  givenname: Yuuki
  surname: Arai
  fullname: Arai, Yuuki
– sequence: 5
  givenname: Shuhei
  surname: Yamakoshi
  fullname: Yamakoshi, Shuhei
– sequence: 6
  givenname: Katsuya
  surname: Yamada
  fullname: Yamada, Katsuya
– sequence: 7
  givenname: Tetsuya
  surname: Ohta
  fullname: Ohta, Tetsuya
– sequence: 8
  givenname: Eiji
  surname: Kawanishi
  fullname: Kawanishi, Eiji
– sequence: 9
  givenname: Naohiro
  surname: Horie
  fullname: Horie, Naohiro
– sequence: 10
  givenname: Takao
  surname: Yamaguchi
  fullname: Yamaguchi, Takao
– sequence: 11
  givenname: Satoshi
  surname: Obika
  fullname: Obika, Satoshi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33179694$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1v1DAQhi1URD_gwh0UiUsFWjr-WCc-lm0pSBU9FM6RY0_AVdZObUdo_z3eZrtIFQdOfjXzvJ7xjI_JgQ8eCXlN4SMFrs4shA6oqsE-I0dU1PUCllwd7DWDQ3Kc0h1sISlekEPOaa2kEkfk9nbj8y9MLlXa22qMYcSYHaYq9NXV9O28GqfoPJ6Nm-jWzhZZ-ckMGJKzOJvC4H6GOZi3wZfkea-HhK925wn58fny--rL4vrm6uvq_HphBPC8sHJpuTGMaQOUGaNr02naSWaksLaTHRNCKtMBayhS3ShBba3rzjKUsgfOT8jpfG_p-n7ClNu1SwaHQXsMU2qZkAANV6AK-u4Jehem6Et3W6oMhUu2LNTbHTV1a7TtWJ6s46Z9HFcBPszAb-xCn4xDb3CPAYCEhkrVFPVQtPl_euWyzi74VZh8LlaYrSaGlCL2rdnlc9RuaCm029W3F3Dz6WH1F8Xy_onlsdI_4TczHJPZc3__Ef8DriG14Q
CitedBy_id crossref_primary_10_1007_s10238_023_01179_x
crossref_primary_10_3390_ijms22073526
crossref_primary_10_1021_acs_jmedchem_1c01680
crossref_primary_10_1016_j_addr_2023_114872
crossref_primary_10_1021_acs_joc_2c01093
crossref_primary_10_1089_nat_2021_0034
crossref_primary_10_1039_D1OB01174J
crossref_primary_10_1016_j_bmcl_2023_129289
crossref_primary_10_1093_nar_gkad608
Cites_doi 10.1021/ja00069a009
10.1073/pnas.91.17.7864
10.1021/ja961308m
10.1039/C4RA14721A
10.1021/acs.orglett.6b00311
10.1002/chem.201704338
10.1021/jo9814445
10.1021/acs.orglett.8b00476
10.1016/0165-1161(83)90010-9
10.1038/nature14138
10.1039/C3CC46017G
10.1201/9780849387951
10.3762/bjoc.14.111
10.1038/374546a0
10.1021/ol049470e
10.1039/C4MD00184B
10.1021/jo9806658
10.1038/s41573-020-0075-7
10.1021/acs.orglett.7b01898
10.1089/nat.2015.0534
10.1080/15257770600793729
10.1039/C8OB01307A
10.1016/0165-1161(94)90037-X
10.1039/c4md00184b
10.1039/c4ra14721a
10.1039/c8ob01307a
10.1212/NXG.0000000000000323
10.1039/c3cc46017g
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2020
Copyright_xml – notice: Copyright Royal Society of Chemistry 2020
DBID AAYXX
CITATION
17B
1KM
AOWDO
BLEPL
DTL
EGQ
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T7
7TM
8FD
C1K
FR3
P64
7X8
DOI 10.1039/d0ob01970d
DatabaseName CrossRef
Web of Knowledge
Index Chemicus
Web of Science - Science Citation Index Expanded - 2020
Web of Science Core Collection
Science Citation Index Expanded
Web of Science Primary (SCIE, SSCI & AHCI)
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biotechnology Research Abstracts
Technology Research Database
Nucleic Acids Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic
MEDLINE
Biotechnology Research Abstracts
Web of Science
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1477-0539
EndPage 9472
ExternalDocumentID 33179694
000608169800009
10_1039_D0OB01970D
d0ob01970d
Genre Journal Article
GrantInformation_xml – fundername: Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED
  grantid: JP19am0101084
GroupedDBID -
0-7
0R
123
1TJ
29N
4.4
70
705
70J
7~J
AAEMU
AAGNR
AAIWI
AANOJ
ABDVN
ABFLS
ABGFH
ABRYZ
ACGFS
ACIWK
ACLDK
ACNCT
ACPRK
ADMRA
ADSRN
AENEX
AFRAH
AFVBQ
AGKEF
AGSTE
AGSWI
ALMA_UNASSIGNED_HOLDINGS
ASKNT
AUDPV
BLAPV
BSQNT
C6K
CKLOX
CS3
D0L
DU5
DZ
EBS
ECGLT
EE0
EF-
F5P
GNO
HZ
H~N
IDZ
J3I
JG
KC5
M4U
N9A
O9-
OK1
P2P
R7B
R7C
RCNCU
RNS
RPMJG
RRA
RRC
RSCEA
SKA
SKF
SLH
TN5
TWZ
UCJ
VH6
VQA
WH7
X
YNT
YZZ
---
-DZ
-~X
0R~
70~
AAJAE
AAMEH
AAWGC
AAXHV
AAXPP
AAYXX
ABASK
ABEMK
ABJNI
ABPDG
ABXOH
AEFDR
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFRDS
AFRZK
AGEGJ
AGRSR
AHGCF
AKMSF
ALUYA
ANUXI
APEMP
CITATION
GGIMP
H13
HZ~
R56
RAOCF
XSW
17B
1KM
BLEPL
DTL
GROUPED_WOS_WEB_OF_SCIENCE
-JG
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T7
7TM
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c403t-d65d3cc22ac012cca7cba1b62c64ddb6b24469cb0281e1a8941d7a7bd2e66f033
ISICitedReferencesCount 10
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000608169800009
ISSN 1477-0520
1477-0539
IngestDate Thu Jul 10 23:03:13 EDT 2025
Mon Jun 30 12:05:15 EDT 2025
Wed Feb 19 02:09:05 EST 2025
Fri Aug 29 16:20:05 EDT 2025
Wed Aug 06 16:19:23 EDT 2025
Tue Jul 01 01:52:09 EDT 2025
Thu Apr 24 23:05:42 EDT 2025
Sat Jan 08 03:48:12 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 46
Keywords 2'-AMINO-LNA
ANALOG
RECOMMENDATIONS
DNA
GUANIDINE
CPG
CATIONIC BACKBONE
Language English
LinkModel OpenURL
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c403t-d65d3cc22ac012cca7cba1b62c64ddb6b24469cb0281e1a8941d7a7bd2e66f033
Notes 10.1039/d0ob01970d
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7742-3939
0000-0003-3180-0257
0000-0002-6842-6812
0000-0002-4220-6328
PMID 33179694
PQID 2467643625
PQPubID 2047497
PageCount 12
ParticipantIDs crossref_citationtrail_10_1039_D0OB01970D
pubmed_primary_33179694
webofscience_primary_000608169800009CitationCount
proquest_journals_2467643625
webofscience_primary_000608169800009
proquest_miscellaneous_2460083909
crossref_primary_10_1039_D0OB01970D
rsc_primary_d0ob01970d
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20201207
PublicationDateYYYYMMDD 2020-12-07
PublicationDate_xml – month: 12
  year: 2020
  text: 20201207
  day: 7
PublicationDecade 2020
PublicationPlace CAMBRIDGE
PublicationPlace_xml – name: CAMBRIDGE
– name: England
– name: Cambridge
PublicationTitle Organic & biomolecular chemistry
PublicationTitleAbbrev ORG BIOMOL CHEM
PublicationTitleAlternate Org Biomol Chem
PublicationYear 2020
Publisher Royal Soc Chemistry
Royal Society of Chemistry
Publisher_xml – name: Royal Soc Chemistry
– name: Royal Society of Chemistry
References Scoles (D0OB01970D-(cit2c)/*[position()=1]) 2019; 5
Ohto (D0OB01970D-(cit9b)/*[position()=1]) 2015; 520
Blaskó (D0OB01970D-(cit4c)/*[position()=1]) 1996; 118
Singh (D0OB01970D-(cit7)/*[position()=1]) 1998; 63
Gatehouse (D0OB01970D-(cit19)/*[position()=1]) 1994; 312
Sharma (D0OB01970D-(cit2b)/*[position()=1]) 2014; 5
Singh (D0OB01970D-(cit11)/*[position()=2]) 2017; 19
Barman (D0OB01970D-(cit4e)/*[position()=1]) 2015; 5
Ravn (D0OB01970D-(cit5)/*[position()=1]) 2006; 25
Dempcy (D0OB01970D-(cit4b)/*[position()=1]) 1994; 91
Sawamoto (D0OB01970D-(cit8)/*[position()=1]) 2018; 20
Crooke (D0OB01970D-(cit2a)/*[position()=1]) 2007
Prakash (D0OB01970D-(cit4d)/*[position()=1]) 2004; 6
Lu (D0OB01970D-(cit12)/*[position()=2]) 2016; 18
Berman (D0OB01970D-(cit17)/*[position()=1]) 2016; 26
Roberts (D0OB01970D-(cit1)/*[position()=1]) 2020; 19
Meng (D0OB01970D-(cit4g)/*[position()=1]) 2018; 14
Shrestha (D0OB01970D-(cit3)/*[position()=1]) 2014; 50
Hashimoto (D0OB01970D-(cit4a)/*[position()=1]) 1993; 115
Singh (D0OB01970D-(cit6)/*[position()=1]) 1998; 63
Basic (D0OB01970D-(cit9a)/*[position()=1]) 1995; 374
Maron (D0OB01970D-(cit18)/*[position()=1]) 1983; 113
Horie (D0OB01970D-(cit14)/*[position()=1]) 2018; 16
Schmidtgall (D0OB01970D-(cit4f)/*[position()=1]) 2018; 24
Ravn, J (WOS:000239453200001) 2006; 25
KRIEG, AM (WOS:A1995QR06900053) 1995; 374
MARON, DM (WOS:A1983QN33600001) 1983; 113
Horie, N (WOS:000444484800019) 2018; 16
Meng, M (WOS:000434080700002) 2018; 14
Barman, J (WOS:000348985400071) 2015; 5
HASHIMOTO, H (WOS:A1993LT67400009) 1993; 115
GATEHOUSE, D (WOS:A1994NQ87500005) 1994; 312
Schmidtgall, B (WOS:000423804800004) 2018; 24
Singh, RP (WOS:000407307900042) 2017; 19
Blasko, A (WOS:A1996VE26600003) 1996; 118
Sharma, VK (WOS:000343023100003) 2014; 5
Singh, SK (WOS:000075892600001) 1998; 63
Singh, SK (WOS:000077834800076) 1998; 63
Roberts, TC (WOS:000559631900001) 2020; 19
Prakash, TP (WOS:000221868300023) 2004; 6
Shrestha, AR (WOS:000328650000022) 2014; 50
Ohto, U (WOS:000353689700055) 2015; 520
DEMPCY, RO (WOS:A1994PC24200008) 1994; 91
(000608169800009.1) 2011
Scoles, DR (WOS:000481665200013) 2019; 5
Sawamoto, H (WOS:000429886900055) 2018; 20
Lu, SH (WOS:000374436800004) 2016; 18
Crooke, S. T. (000608169800009.6) 2007
Berman, CL (WOS:000373927700002) 2016; 26
References_xml – issn: 2007
  publication-title: Antisense Drug Technology: Principles, Strategies, and Applications
  doi: Crooke
– issn: 2011
  publication-title: Macugen® Prescribing Information
– volume: 115
  start-page: 7128
  year: 1993
  ident: D0OB01970D-(cit4a)/*[position()=1]
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja00069a009
– volume: 91
  start-page: 7864
  year: 1994
  ident: D0OB01970D-(cit4b)/*[position()=1]
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.91.17.7864
– volume: 118
  start-page: 7892
  year: 1996
  ident: D0OB01970D-(cit4c)/*[position()=1]
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja961308m
– volume: 5
  start-page: 12257
  year: 2015
  ident: D0OB01970D-(cit4e)/*[position()=1]
  publication-title: RSC Adv.
  doi: 10.1039/C4RA14721A
– volume: 18
  start-page: 1724
  year: 2016
  ident: D0OB01970D-(cit12)/*[position()=2]
  publication-title: Org. Lett.
  doi: 10.1021/acs.orglett.6b00311
– volume: 24
  start-page: 1544
  year: 2018
  ident: D0OB01970D-(cit4f)/*[position()=1]
  publication-title: Chem. – Eur. J.
  doi: 10.1002/chem.201704338
– volume: 63
  start-page: 10035
  year: 1998
  ident: D0OB01970D-(cit7)/*[position()=1]
  publication-title: J. Org. Chem.
  doi: 10.1021/jo9814445
– volume: 20
  start-page: 1928
  year: 2018
  ident: D0OB01970D-(cit8)/*[position()=1]
  publication-title: Org. Lett.
  doi: 10.1021/acs.orglett.8b00476
– volume: 113
  start-page: 173
  year: 1983
  ident: D0OB01970D-(cit18)/*[position()=1]
  publication-title: Mutat. Res.
  doi: 10.1016/0165-1161(83)90010-9
– volume: 520
  start-page: 702
  year: 2015
  ident: D0OB01970D-(cit9b)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/nature14138
– volume: 50
  start-page: 575
  year: 2014
  ident: D0OB01970D-(cit3)/*[position()=1]
  publication-title: Chem. Commun.
  doi: 10.1039/C3CC46017G
– volume-title: Antisense Drug Technology: Principles, Strategies, and Applications
  year: 2007
  ident: D0OB01970D-(cit2a)/*[position()=1]
  doi: 10.1201/9780849387951
– volume: 14
  start-page: 1293
  year: 2018
  ident: D0OB01970D-(cit4g)/*[position()=1]
  publication-title: Beilstein J. Org. Chem.
  doi: 10.3762/bjoc.14.111
– volume: 374
  start-page: 546
  year: 1995
  ident: D0OB01970D-(cit9a)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/374546a0
– volume: 6
  start-page: 1971
  year: 2004
  ident: D0OB01970D-(cit4d)/*[position()=1]
  publication-title: Org. Lett.
  doi: 10.1021/ol049470e
– volume: 5
  start-page: e323
  year: 2019
  ident: D0OB01970D-(cit2c)/*[position()=1]
  publication-title: Neurol.: Genet.
– volume: 5
  start-page: 1454
  year: 2014
  ident: D0OB01970D-(cit2b)/*[position()=1]
  publication-title: MedChemComm
  doi: 10.1039/C4MD00184B
– volume: 63
  start-page: 6078
  year: 1998
  ident: D0OB01970D-(cit6)/*[position()=1]
  publication-title: J. Org. Chem.
  doi: 10.1021/jo9806658
– volume: 19
  start-page: 673
  year: 2020
  ident: D0OB01970D-(cit1)/*[position()=1]
  publication-title: Nat. Rev. Drug Discovery
  doi: 10.1038/s41573-020-0075-7
– volume: 19
  start-page: 4110
  year: 2017
  ident: D0OB01970D-(cit11)/*[position()=2]
  publication-title: Org. Lett.
  doi: 10.1021/acs.orglett.7b01898
– volume: 26
  start-page: 73
  year: 2016
  ident: D0OB01970D-(cit17)/*[position()=1]
  publication-title: Nucleic Acid Ther.
  doi: 10.1089/nat.2015.0534
– volume: 25
  start-page: 843
  year: 2006
  ident: D0OB01970D-(cit5)/*[position()=1]
  publication-title: Nucleosides, Nucleotides Nucleic Acids
  doi: 10.1080/15257770600793729
– volume: 16
  start-page: 6531
  year: 2018
  ident: D0OB01970D-(cit14)/*[position()=1]
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/C8OB01307A
– volume: 312
  start-page: 217
  year: 1994
  ident: D0OB01970D-(cit19)/*[position()=1]
  publication-title: Mutat. Res.
  doi: 10.1016/0165-1161(94)90037-X
– volume: 18
  start-page: 1724
  year: 2016
  ident: WOS:000374436800004
  article-title: Fluorescent Sensing of Guanine and Guanosine Monophosphate with Conjugated Receptors Incorporating Aniline and Naphthyridine Moieties
  publication-title: ORGANIC LETTERS
  doi: 10.1021/acs.orglett.6b00311
– volume: 374
  start-page: 546
  year: 1995
  ident: WOS:A1995QR06900053
  article-title: CPG MOTIFS IN BACTERIAL-DNA TRIGGER DIRECT B-CELL ACTIVATION
  publication-title: NATURE
– volume: 19
  start-page: 4110
  year: 2017
  ident: WOS:000407307900042
  article-title: Tandem Oxidative Dearomatizing Spirocyclizations of Propargyl Guanidines and Ureas
  publication-title: ORGANIC LETTERS
  doi: 10.1021/acs.orglett.7b01898
– volume: 5
  start-page: 1454
  year: 2014
  ident: WOS:000343023100003
  article-title: Antisense oligonucleotides: modifications and clinical trials
  publication-title: MEDCHEMCOMM
  doi: 10.1039/c4md00184b
– year: 2011
  ident: 000608169800009.1
  publication-title: Macugen<(R)>Prescribing Information
– volume: 118
  start-page: 7892
  year: 1996
  ident: WOS:A1996VE26600003
  article-title: Association of short-strand DNA oligomers with guanidinium-linked nucleosides. A kinetic and thermodynamic study
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
– volume: 6
  start-page: 1971
  year: 2004
  ident: WOS:000221868300023
  article-title: 2 '-O-[2-(Guanidinium)ethyl]-modified oligonucleotides: Stabilizing effect on duplex and triplex structures
  publication-title: ORGANIC LETTERS
  doi: 10.1021/ol049470e
– volume: 91
  start-page: 7864
  year: 1994
  ident: WOS:A1994PC24200008
  article-title: DESIGN AND SYNTHESIS OF DEOXYNUCLEIC GUANIDINE - A POLYCATION ANALOG OF DNA
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
– volume: 20
  start-page: 1928
  year: 2018
  ident: WOS:000429886900055
  article-title: Synthetic Method for 2 '-Amino-LNA Bearing Any of the Four Nucleobases via a Transglycosylation Reaction
  publication-title: ORGANIC LETTERS
  doi: 10.1021/acs.orglett.8b00476
– volume: 26
  start-page: 73
  year: 2016
  ident: WOS:000373927700002
  article-title: OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based Therapeutics
  publication-title: NUCLEIC ACID THERAPEUTICS
  doi: 10.1089/nat.2015.0534
– volume: 5
  start-page: 12257
  year: 2015
  ident: WOS:000348985400071
  article-title: 2 '-N-Guanidino, 4 '-C-ethylene bridged thymidine (GENA-T) modified oligonucleotide exhibits triplex formation with excellent enzymatic stability
  publication-title: RSC ADVANCES
  doi: 10.1039/c4ra14721a
– year: 2007
  ident: 000608169800009.6
  publication-title: Antisense Drug Technology: Principles, Strategies, and Applications
– volume: 113
  start-page: 173
  year: 1983
  ident: WOS:A1983QN33600001
  article-title: REVISED METHODS FOR THE SALMONELLA MUTAGENICITY TEST
  publication-title: MUTATION RESEARCH
– volume: 16
  start-page: 6531
  year: 2018
  ident: WOS:000444484800019
  article-title: Facile synthesis and fundamental properties of an N-methylguanidine-bridged nucleic acid (GuNA[NMe])
  publication-title: ORGANIC & BIOMOLECULAR CHEMISTRY
  doi: 10.1039/c8ob01307a
– volume: 115
  start-page: 7128
  year: 1993
  ident: WOS:A1993LT67400009
  article-title: ZWITTERIONIC DNA
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
– volume: 5
  start-page: ARTN e323
  year: 2019
  ident: WOS:000481665200013
  article-title: Antisense oligonucleotides
  publication-title: NEUROLOGY-GENETICS
  doi: 10.1212/NXG.0000000000000323
– volume: 520
  start-page: 702
  year: 2015
  ident: WOS:000353689700055
  article-title: Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
  publication-title: NATURE
  doi: 10.1038/nature14138
– volume: 63
  start-page: 6078
  year: 1998
  ident: WOS:000075892600001
  article-title: Synthesis of novel bicyclo[2.2.1] ribonucleosides: 2 '-amino- and 2 '-thio-LNA monomeric nucleosides
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
– volume: 24
  start-page: 1544
  year: 2018
  ident: WOS:000423804800004
  article-title: Oligonucleotides with Cationic Backbone and Their Hybridization with DNA: Interplay of Base Pairing and Electrostatic Attraction
  publication-title: CHEMISTRY-A EUROPEAN JOURNAL
  doi: 10.1002/chem.201704338
– volume: 25
  start-page: 843
  year: 2006
  ident: WOS:000239453200001
  article-title: Synthesis of 2 '-amino-LNA purine nucleosides
  publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
  doi: 10.1080/15257770600793729
– volume: 312
  start-page: 217
  year: 1994
  ident: WOS:A1994NQ87500005
  article-title: RECOMMENDATIONS FOR THE PERFORMANCE OF BACTERIAL MUTATION ASSAYS
  publication-title: MUTATION RESEARCH
– volume: 63
  start-page: 10035
  year: 1998
  ident: WOS:000077834800076
  article-title: Synthesis of 2 '-amino-LNA: A novel conformationally restricted high-affinity oligonucleotide analogue with a handle
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
– volume: 14
  start-page: 1293
  year: 2018
  ident: WOS:000434080700002
  article-title: Oligonucleotide analogues with cationic backbone linkages
  publication-title: BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY
  doi: 10.3762/bjoc.14.111
– volume: 19
  start-page: 673
  year: 2020
  ident: WOS:000559631900001
  article-title: Advances in oligonucleotide drug delivery
  publication-title: NATURE REVIEWS DRUG DISCOVERY
  doi: 10.1038/s41573-020-0075-7
– volume: 50
  start-page: 575
  year: 2014
  ident: WOS:000328650000022
  article-title: Guanidine bridged nucleic acid (GuNA): an effect of a cationic bridged nucleic acid on DNA binding affinity
  publication-title: CHEMICAL COMMUNICATIONS
  doi: 10.1039/c3cc46017g
SSID ssj0019764
Score 2.3774214
Snippet We recently designed guanidine-bridged nucleic acids (GuNA), and GuNA bearing a thymine (T) nucleobase was synthesized and successfully incorporated into...
Source Web of Science
SourceID proquest
pubmed
webofscience
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 9461
SubjectTerms Adenine
Antisense oligonucleotides
Antisense therapy
Bases (nucleic acids)
Chemistry
Chemistry, Organic
Exonuclease
Genotoxicity
Guanidine
Guanine
Mutation
Nucleic acids
Nucleosides
Oligonucleotides
Oligonucleotides - chemical synthesis
Oligonucleotides - chemistry
Physical Sciences
Purine Nucleosides - chemical synthesis
Purine Nucleosides - chemistry
Pyrimidine Nucleosides - chemical synthesis
Pyrimidine Nucleosides - chemistry
Science & Technology
Synthesis
Therapeutic applications
Thymine
Title Synthesis and properties of GuNA purine/pyrimidine nucleosides and oligonucleotides
URI http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000608169800009
https://www.ncbi.nlm.nih.gov/pubmed/33179694
https://www.proquest.com/docview/2467643625
https://www.proquest.com/docview/2460083909
Volume 18
WOS 000608169800009
WOSCitedRecordID wos000608169800009
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgO8AF8TUIDBTELmgKS5zUro-lGxSExqGdNE6Vv1IKI6m6RGj89TzbSRxokQaXqPJHXPn9Yv_e8_N7CB0Ag09yTY1dg-MoE5xFPE5UNJA57OY5FlRYL99TMjnLPpwPzr3rkL1dUonX8ufWeyX_I1UoA7maW7L_INnupVAAv0G-8AQJw_NaMp5eFcDfTEgRd92_XBkvaRdG9l19OjpcGVu6Ngl2r0z6LmUoZWEiGJcmS6frVl4sF6UrrExhn666m5rS4sNc1G9z6R7KNk-cPwr6zhcutfX0y7L4uuxMN_wHBzhYi-xkuS6BsXprwTe9gOpotOYue_YMhvAQdK_7XNdNl8Y4gZ2jB-2tpxmlkXG1cdtNv8zFMNpchOs2TGizpLLMRWtvtmeWuVQ_G0t_nJrIqSouBbBWGiu_wXVuh77yJtrFoFfAwrg7Opm9_9gdPAE7s44I7f9uI9qm7Mj3_p3DbCgmQFPWl3Irk7GsZXYX3WnUjXDksHMP3dDFfXRr3ErvAZp2GAoBDKHHUFjmocFQ6DB05BEU9hBkO_2JoIfo7O3JbDyJmkQbkczitIoUGahUSoy5BL4C3zSVgieCYEkypQQRwAEJkwK4aKITPmRZoiinQmFNSB6n6R7aKcpCP0ZhzLM85SmOhxp0z1wKybimcogVtMSEBuhVO3Vz2UShN8lQLubWGyJl8-P40xs7zccBetm1XbnYK1tb7bcSmDff5uUcw_4PXBuU-wC96Kphas1xGC90Wds2RgFhMQvQIye5bpgUaDUjLAvQHoiyK_YQCNBBX7pdCxvgaJgQNrTaV4CS6zQbNzNh4lBUT_425lN0239j-2inWtf6GVDiSjxvYPwLNgK43g
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+properties+of+GuNA+purine%2Fpyrimidine+nucleosides+and+oligonucleotides&rft.jtitle=Organic+%26+biomolecular+chemistry&rft.au=Kumagai%2C+Shinji&rft.au=Sawamoto%2C+Hiroaki&rft.au=Takegawa-Araki%2C+Tomo&rft.au=Arai%2C+Yuuki&rft.date=2020-12-07&rft.issn=1477-0520&rft.eissn=1477-0539&rft.volume=18&rft.issue=46&rft.spage=9461&rft.epage=9472&rft_id=info:doi/10.1039%2Fd0ob01970d&rft.externalDocID=d0ob01970d
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0520&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0520&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0520&client=summon